...
首页> 外文期刊>Advances in Biological Chemistry >Hepatoprotective Effects of the Leaves of Agauria salicifolia against Acetaminophen-Induced Liver Injury in Mice
【24h】

Hepatoprotective Effects of the Leaves of Agauria salicifolia against Acetaminophen-Induced Liver Injury in Mice

机译:糖尿病叶片对小鼠乙酰氨基酚诱导肝损伤的肝脏保护作用

获取原文

摘要

Agauria salicifolia (Ericaceae) is a medicinal plant traditionally used for the treatment of liver ailments. The present study investigates the hepatoprotective effect of the residual aqueous fraction (RAF) of Agauria salicifolia on acetaminophen (APAP)-induced liver damage. The ethanol extract obtained as maceration of the dried leaves, was fractionated into hexane, ethyl acetate and residual aqueous fractions. Adult mice of both sexes were pre-treated with the reference drug silymarin (50 mg/kg) or RAF (100 and 200 mg/kg) during 6 days followed by a single administration of APAP (500 mg/kg) on day 7. The hepatoprotective effect and the contribution of antioxidant activities were evaluated by determining the level of transaminases in serum samples, the levels of proteins, nitric oxide (NO), malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase in liver homogenates. Histological analyses of liver slides were also performed. RAF at the doses of 100 and 200 mg/kg and silymarin significantly (p 0.001) decreased serum level of alanine and aspartate aminotransferases. RAF showed no effect on liver weight and its SOD content but significantly inhibited the increase in proteins (p 0.01), NO (p 0.01) and MDA (p 0.001) induced by APAP while silymarin significantly reduced all these parameters. RAF and silymarin also significantly (p 0.05) increased the GSH and catalase content in the liver as compared to the APAP treated group. The vascular congestion, leukocyte infiltration and loss of hepatocytes and liver architecture observed in the liver tissue of disease control mice were corrected in animals treated with RAF. Therefore, it can be concluded that RAF possesses hepatoprotective activities that might be mediated at least partially by its antioxidant effects.
机译:艾西乳酸(Ericaceae)是一种传统上用于治疗肝脏疾病的药用植物。本研究研究了阿加里亚沙利米菌对乙酰氨基酚(APAP)诱导的肝损伤的肝脏保护作用。将作为干燥叶片的丙烷的乙醇提取物分离成己烷,乙酸乙酯和残留的含水级分。在6天内用参考药物甲硅烷蛋白(50mg / kg)或RAF(100和200mg / kg)预处理两种性别的成人小鼠,然后在第7天进行APAP(500mg / kg)。通过测定血清样品中的转氨酶水平,蛋白质,一氧化氮(NO),丙二醛(MDA),谷胱甘肽(GSH),超氧化物歧化酶(SOD)和过氧化氢酶来评估抗氧化剂活性的抗氧化活性的贡献和抗氧化剂活性的贡献。在肝脏匀浆中。还进行了肝脏载玻片的组织学分析。 RAF在100和200mg / kg和西里马林的剂量下显着(p <0.001)降低血清丙氨酸和天冬氨酸氨基转移酶。 RAF对肝脏重量和SOD含量没有影响,但显着抑制了APAP诱导的蛋白质(P <0.01),NO(P <0.01)和MDA(P <0.001)的增加,而Silymarin显着降低所有这些参数。与APAP处理组相比,RAF和Silymarin也显着增加(P <0.05)增加了肝脏中的GSH和过氧化氢酶含量。在用RAF处理的动物中校正了在疾病对照小鼠的肝脏组织中观察到的血管充血,白细胞浸润和肝细胞和肝脏结构的丧失。因此,可以得出结论,RAF具有肝脏保护活性,其可能通过其抗氧化效果至少部分地介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号